Camrelizumab and rivoceranib, which were chosen to be combined with TACE, were approved as standard first-line treatment for unresectable HCC in CARES-310 study. The final results of the CARES-310 ...

However, the genomic heterogeneity in ctDNA during treatments and its impact on clinical outcomes remain largely unknown. Design We conducted a prospective cohort study (NCT04228614) of 171 patients ...

Marwan G. Fakih, MD, explains the implications of the findings from the phase 2 trial of balstilimab plus botensilimab for the treatment of patients with microsatellite stable metastatic colorectal ...

1Department of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas. *Corresponding Author: John Paul Shen, Department of Colon and Rectal Surgery, The ...

Adenomatous polyps typically do not cause symptoms unless they progress to colon cancer. Even then, there may be no sign of a problem until the malignancy is advanced. This is why colon cancer ...

Nancy Leftenant-Colon, who battled racial discrimination in a barrier-breaking career as a military nurse, serving as the first African American in the regular Army Nurse Corps and later caring ...

Should the primary tumor, if asymptomatic, be resected in patients with colon cancer with synchronous unresectable metastases? Study results hint that the answer is no. FOLFOXIRI plus panitumumab ...

Toxicology and clinical protocol development of DUO-207: An ultrasmall nanomedicine co-delivering gemcitabine and paclitaxel for the treatment of metastatic pancreatic cancer. This is an ASCO Meeting ...

A multicenter, prospective observational study of chemotherapy in elderly patients with biliary tract cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium.

Dr. Kim’s clinical and research interests focus on gastrointestinal tumors, in particular hepatobiliary and colon cancer. He is a principal investigator in multiple investigator-initiated and ...

"The CARES-oo5 study showed a clinically meaningful and statistically significant improvement in the primary endpoint of PFS for unresectable HCC who received TACE plus immunotherapy-based ...

Colon cancer cases are soaring in young people, alarming experts and leaving doctors scrambling for answers as to why. Now, a study published by a team of international researchers in the journal ...